Closing Lecture :: Repositioning of drugs, a useful strategy in drug discovery and development
Repositioning of drugs, a useful strategy in drug discovery and development Eliezer Barreiro (UFRJ) Chair: Marco Aurélio Martins (Fiocruz)
SBFTE
MIMESIS, Mimicking viruses strategies for innovative drug discovery
ENYO Pharma is a privately held biopharmaceutical company with an innovative drug discovery approach inspired by viruses. Our biotech mimics virus strategy ...
ENYO Pharma
Peptide Design Strategy Basics, Optimization, and Application
Is your peptide sequence optimally designed for your unique research application? Peptide design effects the overall stability and usability of your peptide in ...
GenScript USA Inc.
Computer-aided Drug Discovery and Structure-based Drug Design
Computer-aided Drug Discovery and Structure-based Drug Design By Kumar Reddy, Department of Animal Biology, School of Life Sciences, University of ...
ELC UoH
Drug Design Recorded Lecture 1
Jacques Joubert
Computational Drug Discovery: Machine Learning for Making Sense of Big Data in Drug Discovery
In this lecture, I provide an overview on how computers can be instrumental in drug discovery efforts. Topics covered includes: big data from omics effort; ...
Data Professor
Organic pharmaceutical chemistry Dr.mazin (drug design strategy 2)
PH 19 vedios
Lead Discovery and Optimization and Analog Design - An Infographic
We, The Pharmaceutical Chemistry 180 PHA Section AY 2018-2019, bring you: Lead Discovery and Optimization and Analog Design - An Infographic. As Future ...
Alfonzo Castalone
Application of Molecular Modeling Tools in Drug Discovery
Session 2: “Application of Molecular Modeling Tools in Drug Discovery” by Dr. S. Murugesan, Associate Professor, Medicinal Chemistry Research Laboratory, ...
Molecules - For Life
webinar recording: structure-based drug design of selective Drp1 inhibitors
The mitochondrial protein dynamin-related protein (Drp1) has been implicated in the development of a number of diseases, including cancer, heart disease and ...
BioSolveITTutorials
Drug discovery and pharmacology of antivirals targeting drug-resistant influenza viruses
Presented By: Jun Wang, PhD Speaker Biography: Dr. Wang received his bachelor degree in chemistry from Wuhan University, China, in 2003. After a one year ...
LabRoots
Protein/BioNMR as a powerful tool for drug discovery
David discusses the power of Protein/BioNMR in 3D structural analysis of proteins, protein-ligand complexes and macrocycles, and assessing the binding ...
Abzena
Sunayana Mam,Various approach in drug design : ligand based drug design
Download Telegram App from Google Play Store From this link https://telegram.org/dl And Join Our Channel "ADINA PHARMACY Notes &Lectures" for All ...
ADINA PHARMACY VIDEO LECTURE
A Data-Driven Perspective on Drug Discovery
Online lecture by Dr. Raghvendra Mall and Dr. Ehsan Ullah. This is the fifth lecture in the series "AI and Data Science for COVID-19 Data" lecture series by the ...
QatarComputing
Advancing Early Cardiovascular Drug Discovery
The story presented in this webinar shows an excellent example of a partnership in action for developing new treatments to support unmet pharmaceutical ...
GENNews
Certificate in Drug Discovery & Development (DDD) - Recorded Information Session
Hear from HSC College of Pharmacy faculty to learn more about Drug Discovery & Development career and graduate program pathways, the science behind ...
UNT Health Science Center
Synthetic Antibodies - The Emerging Field of "Aptamers" in Diagnostics and Drug Discovery
Presented At: LabRoots - Drug Discovery Virtual Event 2019 Presented By: G. Thomas Caltagirone, PhD - President & CEO, Aptagen, LLC Speaker Biography: ...
LabRoots
Pharmacokinetics in Drug Development
Part of the CCTS drug discovery seminar series. Speaker Edward Acosta, PharmD. Recorded April 1, 2019 @ PCAMS on the campus of UAB.
CCTS
Drug Discovery - Module 6, Session 1
Drug Discovery - Module 6, Session 1 with Dr. Edward Sausville This is Module 6, Session 1, of the NIH Clinical Center's "Principles of Clinical Pharmacology" ...
NIH Clinical Center
Medicinal Chemistry From Hit-to-Lead
Part of the CCTS drug discovery seminar series. Speaker Ashish Pathak, PhD.. Recorded March 18 2019 @ PCAMS on the campus of UAB. www.uab.edu/ccts.
CCTS
5 Things Big Pharma Can Expect from the 2020s / Episode 13 - The Medical Futurist
The global revenue of the pharmaceutical market is 1.2 trillion dollars. With such capital at stake and with the pace of technological disruption, the pharma ...
The Medical Futurist
Microbial Bioconversion:A Regio-specific Method for Drug Design & Toxicological Study of Metabolites
Microbial Bioconversion: A Regio-specific Method for Novel Drug Design and Toxicological Study of Metabolites https://www.eurekaselect.com/172712/article ...
Bentham Science
Structural Biology Behind Disease Transmission and Drug Design - Virtual Panel Discussion
More info and downloads: https://dnalc.cshl.edu/resources/dnalc-live/ In collaboration with the Long Island STEM Hub, Brookhaven National Laboratory's (BNL) ...
DNA Learning Center
Oligo Meeting 2017 - RNAi Drug Discovery
Martin Maier, PhD, Alnylam Pharma.
Oligonucleotide Therapeutics Society
Virtual drug discovery - the challenges and opportunities for biotech
Video from the 'Outsourcing Strategies in Biotech/Pharmaceuticals' Symposium, 23 November 2011, Clare College, Cambridge, UK.
Royal Society Of Chemistry
Computer-aided Drug Discovery and Structure-based Drug Design
By Kumar Reddy, Department of Animal Biology, School of Life Sciences, University of Hyderabad.
ELC UoH
Spotlight on Epigenetics Drug Discovery
Rockland Immunochemicals was a proud sponsor of The Scientist's Spotlight on Epigenetics Drug Discovery. This webinar brings together a panel of experts to ...
Rockland Immunochemicals, Inc.
Anti-idiotype Antibody Generation and Application in Antibody Drug Discovery
An idiotype can be defined as the specific combination of idiotopes present within an antibody complementarity-determining regions. Since anti-ID Abs are ...
GenScript USA Inc.
Antimicrobial Resistance in Drug Discovery: Q&A
Recording of 'Bootcamp 1: Understanding the Potential for Antimicrobial Resistance in the Drug Discovery Process' at the ASM/ESCMID Conference on Drug ...
GARDP
Re-introducing the Patient Context into Cardiac Drug Discovery Using iPSCs
Re-introducing the Patient Context into Cardiac Drug Discovery Using iPSCs - Mark Mercola Scientific Symposium from the American Society of Gene & Cell ...
ASGCT
Drug Design lecture 7 8
Drhany hafez
What are the benefits of using SPR in FBDD and/or drug discovery
Is it possible to identify true hits just based on affinity data? Join our experts and discuss the value of SPR data—what you can gain and how to best utilize the ...
Cytiva
11 Drug Design.mp4
Table of Contents: 00:00 - Medicine and Drugs: Drug Design 00:42 - Strategies for Drug Design 01:19 - Rational Drug Design 03:00 - Rational Drug Design ...
Theresa McCafferty
The drug discovery concept – general strategy
The drug discovery concept – general strategy.
Dr S H FAIZI
Integrating In Vitro Microtissues and In Vivo endpoints in Drug Discovery & Development
Presented At: Laboratory Animal Sciences Virtual Event 2019 Presented By: Matthew Wagoner, PhD - Associate Director of Mechanistic and Investigative ...
LabRoots
Drug Discovery and Development Segment 1
In this lecture • Aim of drug discovery and development • Small molecules, biologics • Drug discovery and Drug invention • Strategies employed for inventing ...
sam w
INTRODUCTION_TO_DRUG_DESIGN || B.PHARM || M.PHARM || MEDICINAL_CHEMISTRY GPAT || NIPER || PCI
DRUGDDESIGN, #MOLECULARMODELLING #AKTU #MEDICNAL CHEMISTRY THIS PRESENTATION GIVES COMPLETE OUTLINE OF INTRODUCTION ...
Nids Pharma Classes #ChemistrykiPaathsaala - NPC
Biased ligands in Drug Discovery: the case of TRV027 - Webinar
Ligand bias is a well-established concept in the GPCR research field that is beginning to emerge as a means to optimise GPCR targeted drug design.
Cisbio
Drug Discovery in a University: Fact or Fiction?
Chemistry lies at the heart of drug discovery and synthetic medicinal chemists play a pivotal role since, at least for small molecule drugs, their skills define ...
Royal Society Of Chemistry
Drug Design and Molecular Modelling | By Prof.Dr.Cinu Thomas | ChemTalks
Sorry about the low quality of the video This is the highlights of a webinar hosted by Al-Azhar College of Pharmacy Thodupuzha The Speaker for the webinar is ...
ChemTalks
Can CADD Drive GPCR Drug Design? Rapid Estimation of Relative Binding Affinities Based on..
Presented at: Drug Discovery 2018 Presented By: Alexander MacKerell, PhD - Grollman-Glick Professor of Pharmaceutical Sciences, Director, Computer-Aided ...
LabRoots
Acoustic Liquid Handling Is Integral for Successful Cancer Drug Discovery
In this GEN webinar, our panelists will discuss their methods for trying to identify new therapeutic compounds in the fight against cancer and how acoustic liquid ...
GENNews
